Acro Biomedical (ACBM) Non-Current Debt (2021 - 2022)
Acro Biomedical's quarterly Non-Current Debt came in at $78826.0 in Q4 2022, up 280.05% year-on-year from $20741.0 in Q4 2021, and up 280.05% quarter-over-quarter from $20741.0 in Q4 2021.
Acro Biomedical has reported Non-Current Debt for 2 years, with the latest figure at $78826.0 in Q4 2022.
- For the quarter ending Q4 2022, Non-Current Debt rose 280.05% year-over-year to $78826.0; the trailing twelve-month figure through Dec 2022 stood at $78826.0 (up 280.05% YoY), and the FY2022 full-year result was $78826.0, up 280.05% from the prior year.
- Non-Current Debt for Q4 2022 stood at $78826.0, up from $20741.0 in the prior quarter.
- The five-year high for Non-Current Debt was $78826.0 in Q4 2022, with the low at $20741.0 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | - |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | 542,975.00 |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | - |
| 10 | Acro Biomedical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 78,826.00 |
| Dec 31, 2022 | 78,826.00 |
| Dec 31, 2021 | 20,741.00 |
| Dec 31, 2021 | 20,741.00 |